新闻资讯

Filter By:
新闻室
18-07-2018

Frontage Laboratories Recognized as “Fastest Growing Company” by INC Magazine

Exton, P.A. – August 22, 2014 – Frontage today announced recognition by INC Magazine in the INC 5000. For the second time in three years, Frontage earned a spot on the magazine’s thirty-third annual compilation of America’s fastest-growing privately-held companies.
查看详情
新闻室
18-07-2018

Tigermed and Frontage Laboratories Complete Strategic Investment Agreement

Exton, P.A., (July 30, 2014) – Hangzhou Tigermed Consulting Co., Ltd. and Frontage Laboratories, Inc. today announced completion of the previously announced investment agreement, following approval by the China Securities and Regulatory Commission.
查看详情
新闻室
18-07-2018

Frontage acquires Concord Biosciences

Frontage Laboratories, Inc., a global CRO with headquarters in Exton, Pennsylvania, announces the acquisition of Concord Biosciences, formerly known as Ricerca Biosciences, LLC, a preclinical CRO located near Cleveland, Ohio. Founded in 1986, Concord Bio supports the pharmaceutical, agricultural, chemical, and animal health industries with Drug Safety, Metabolism, Bioanalytical, Residue, and Environmental Fate studies.
查看详情
新闻室
17-07-2018

Frontage Receives 2018 CRO Leadership Awards

Exton, P.A., July 11, 2018: Frontage Laboratories, Inc. has been named as a 2018 CRO Leadership Awards recipient by Life Science Leader magazine. The publication annually asks pharmaceutical and biopharmaceutical companies to rate the capability and performance of contract research organizations.
查看详情
新闻室
21-06-2018

Frontage Appoints Hugh Davis as Chief Business Officer

Frontage Laboratories, Inc., is pleased to announce the appointment of Dr. Hugh Davis as Chief Business Officer (CBO), in charge of Business Development, Sales, Marketing and Strategic Partnerships.
查看详情
新闻室
21-06-2018

Dr. Song Li Wins Healthcare CEO Enterprise Award

Dr. Song Li, Founder and CEO of Frontage Laboratories, Inc., has been awarded the Healthcare CEO of the Year Enterprise Award for 2018.
查看详情